Dr. Treichler joined Catalent Biologics in 2017 supporting the company’s biologics drug substance and drug product business areas. Prior to joining Catalent, she worked in senior product management roles in biologics drug substance, medical devices, and diagnostics industries, and was instrumental in launching products for bioprocessing, organ transplant, and food safety testing. Dr. Treichler received a bachelor’s degree in biology from Ursinus College, and a doctorate in molecular biology from Rutgers University, New Jersey.